BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Ignite II - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://gmkb.org
X-WR-CALDESC:Events for Ignite II
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231002
DTEND;VALUE=DATE:20231005
DTSTAMP:20260426T033203
CREATED:20221202T182353Z
LAST-MODIFIED:20221202T182353Z
UID:2885-1696204800-1696463999@gmkb.org
SUMMARY:G2MC 7th International Conference
DESCRIPTION:October 2-4\, 2023 | Online & Geneva\, Switzerland \nThe Global Genomic Medicine Consortium (G2MC) 7th International Conference will be held October 2-4\, 2023 in Geneva\, Switzerland. For those unable to attend in person\, we will also be incorporating virtual sessions. \nThe theme of the 2023 conference is connecting with governing bodies and organizations\, particularly LMICs\, to enhance collaborations to ultimately influence genomic medicine implementation worldwide. \nVisit the conference website for more information.
URL:https://gmkb.org/event/g2mc-7th-international-conference/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231004T150000
DTEND;TZID=America/New_York:20231004T170000
DTSTAMP:20260426T033203
CREATED:20230920T171413Z
LAST-MODIFIED:20230920T171424Z
UID:3497-1696431600-1696438800@gmkb.org
SUMMARY:Cystic Fibrosis: Precision Treatment of a Rare Monogenic Disease
DESCRIPTION:Wednesday\, October 4 | 3 – 5 p.m. ET | Online \nJoin the UNC Program for Precision Medicine in Healthcare (PPMH) for Cystic Fibrosis: Precision Treatment of a Rare Monogenic Disease\, a free virtual mini-symposium. At this interactive event\, participants will engage in discussion with leading precision nutrition researchers at UNC. \nPresentation: Developing small-molecule therapies to rescue rare CFTR variants\nSpeaker:\nRhianna Lee\, PhD\nPostdoctoral associate\, Duke University\, Cell Biology Department \nPresentation: Personalized medicine\, the fight against antibiotic resistance\, and precision dosing\nSpeaker:\nGauri Rao\, PharmD\nAssociate Professor\, USC Mann School of Pharmacy and Pharmaceutical Sciences\, University of Southern California\nAdjunct Associate Professor\, UNC Eshelman School of Pharmacy\, UNC Chapel Hill \nPresentation: From Data to Dosing: Streamlining CF Modulator Choices\nSpeaker:\nMichael Adams\, MD\nClinical Instructor\, Division of Genetics & Metabolism\, Department of Pediatrics\, UNC School of Medicine \nLearn more and register on the PPMH website.
URL:https://gmkb.org/event/cystic-fibrosis-precision-treatment-of-a-rare-monogenic-disease/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231018T150000
DTEND;TZID=America/New_York:20231018T161500
DTSTAMP:20260426T033203
CREATED:20231012T144405Z
LAST-MODIFIED:20231012T144703Z
UID:3521-1697641200-1697645700@gmkb.org
SUMMARY:PRS for the PCP: Evaluating polygenic risk scoring in primary care with clinical trials
DESCRIPTION:Wednesday\, October 18 | 3 – 4:15 p.m. ET | Online\n \nBeginning September 2022\, NHGRI will host a new seminar series based on its Genomic Innovator Award Program\, which supports innovative work by early-career genomics investigators who are part of consortia or other team-science efforts. Each seminar will feature an early-career researcher and an established researcher. Their presentations will cover specific topics that showcase the creative ways that early-career investigators are accelerating genomics research. \nEach seminar will include two speakers (each giving 20-minute talks) followed by a moderated Q&A session. \nThis seminar will be presented by speakers: \nKatrina A.B. Goddard\, Ph.D.\nDirector\, Division of Cancer Control and Population Sciences\nNational Cancer Institute \nJason L. Vassy\, M.D.\, MPH\, M.S.\nAssociate Professor of Medicine; Clinician-Investigator; Founding Member of Precision Population Health\nHarvard Medical School; Veterans Affairs (VA) Boston Healthcare System and Brigham and Women’s Hospital; Ariadne Labs \nPlease note: registration is required. Learn more and register on the Genomic Innovator Seminar Series website.
URL:https://gmkb.org/event/3521/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231026T070000
DTEND;TZID=America/New_York:20231026T080000
DTSTAMP:20260426T033203
CREATED:20231016T155047Z
LAST-MODIFIED:20231016T155047Z
UID:3552-1698303600-1698307200@gmkb.org
SUMMARY:Challenges\, Insights and Outcomes of a Clinically Integrated Multi-omic Rare Disease Program
DESCRIPTION:Challenges\, Insights and Outcomes of a Clinically Integrated Multi-omic Rare Disease Program\, RDNow\, for Individuals Who Remain Undiagnosed After Clinical Genomic Sequencing \nThursday\, October 26 | 7 a.m. ET | Online \nSpeaker: Dr. Michelle de Silva \nMichelle is an associate genetic counselor with a PhD in molecular genetics. She is an experienced medical researcher and has managed several multidisciplinary research centres at the University of Melbourne\, while also working as the program manager of the Rare Disease Flagship and RDNow Program at Murdoch Children’s Research Institute in Melbourne. \nTo learn more and register\, visit the GGMC Educational Webinar Series webpage. \nPlease note: Registration is required for this webinar.
URL:https://gmkb.org/event/challenges-insights-and-outcomes-of-a-clinically-integrated-multi-omic-rare-disease-program/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231026T110000
DTEND;TZID=America/New_York:20231026T120000
DTSTAMP:20260426T033203
CREATED:20230719T131639Z
LAST-MODIFIED:20230719T131639Z
UID:3449-1698318000-1698321600@gmkb.org
SUMMARY:Cost-Effectiveness Analysis in Public Health Genomics & Precision Health
DESCRIPTION:Thursday\, October 26 | 11 a.m. – 12 p.m. ET | Online \n\nCDC Webinar – Cost-Effectiveness Analysis in Public Health Genomics and Precision Health: Recent Findings\, Methodologic Issues\, and the Path Forward \nSpeaker:\nDavid Veenstra\, PhD\nProfessor in the Department of Pharmacy and the Comparative Health Outcomes\, Policy & Economics (CHOICE) Institute\nUniversity of Washington \nPlease note: registration is required. Visit the CDC Genomics & Precision Health event page to learn more and sign up.
URL:https://gmkb.org/event/cost-effectiveness-analysis-in-public-health-genomics-precision-health/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231030T140000
DTEND;TZID=America/New_York:20231030T150000
DTSTAMP:20260426T033203
CREATED:20230920T160159Z
LAST-MODIFIED:20230920T160159Z
UID:3492-1698674400-1698678000@gmkb.org
SUMMARY:NHGRI Division of Intramural Research Seminar
DESCRIPTION:Monday\, October 30 | 2 – 3 p.m. | Bethesda\, MD & Online \nThe Division of Intramural Research (DIR) sponsors a monthly series of talks by intramural and special guest speakers celebrating genetics and genomics research. Speakers are selected by NHGRI intramural faculty and trainees and cover research topics of interest to a wide audience. \nAll seminars are free and open to the public. Seminar titles and other details are updated on the NHGRI website as information becomes available. \nSpeaker:\nMatthew Hurles\, FMedSci\, FRS\nDirector\, Wellcome Sanger Institute \nCo-Host:\nEric Green\, NHGRI Office of the Director \nView past presentations\, learn more about upcoming seminars\, and register to attend on the NHGRI website.
URL:https://gmkb.org/event/nhgri-division-of-intramural-research-seminar-3/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231031T130000
DTEND;TZID=America/New_York:20231031T140000
DTSTAMP:20260426T033203
CREATED:20231029T203025Z
LAST-MODIFIED:20231029T205222Z
UID:3580-1698757200-1698760800@gmkb.org
SUMMARY:FDA Webinar | Proposed Rule: Medical Devices; Laboratory Developed Tests
DESCRIPTION:Proposed Rule: Medical Devices; Laboratory Developed Tests \nTuesday\, October 31 | 1 p.m. ET | Online \nThe U.S. Food and Drug Administration (FDA) will host a public webinar to provide information on the proposed rule regarding Laboratory Developed Tests (LDTs). During the webinar\, the FDA will: \n\nProvide an overview of the rulemaking proposal to amend the FDA’s regulations to make explicit that in vitro diagnostic products (IVDs) are devices under the Federal Food\, Drug\, and Cosmetic Act including when the manufacturer of the IVD is a laboratory.\nDescribe the proposed phaseout of FDA’s general enforcement discretion approach to LDTs.\nHost a Q&A session based on questions that have been submitted prior to the webinar at CDRHWebinars@fda.hhs.gov. Questions will not be taken during the live webinar. All questions are due by October 23\, 2023\, to be considered for the discussion.\n\nRegistration is not required. To learn more and access the Zoom webinar details\, visit the event page.
URL:https://gmkb.org/event/fda-webinar-proposed-rule-medical-devices-laboratory-developed-tests/
LOCATION:Virtual
END:VEVENT
END:VCALENDAR